Air Pollution (PM2.5) on Accelerated Atherosclerosis: A Montelukast Interventional Study in Modernizing China

NCT04762472 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

200

Enrollment

OTHER

Sponsor class

Conditions

Atherosclerosis, Coronary

Interventions

DRUG: Montelukast Oral Tablet
DRUG: Montelukast Placebo Oral Tablet

Sponsor

Chinese University of Hong Kong

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]